Loading organization details...
Loading organization details...
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2024
Total Revenue
▼$249.6K
Program Spending
84%
of total expenses go to program services
Total Contributions
$249.6K
Total Expenses
▼$246.7K
Total Assets
$3,866
Total Liabilities
▼$0
Net Assets
$3,866
Officer Compensation
→$32K
Other Salaries
$78.1K
Investment Income
$0
Fundraising
▼N/A
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$6.3M
Awards Found
46
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| National Science Foundation | SBIR PHASE II: DEVELOPMENT OF A STOICHIOMETRIC, DIRECT-INJECTED, SOOT-FREE ENGINE FOR HEAVY-DUTY APPLICATIONS | $1.4M | FY2019 | Apr 2019 – Feb 2023 |
| Department of Energy | COMBUSTION GEOMETRY OPTIMIZATION TO INCREASE ALCOHOL-FUELED MCCI EFFICIENCY | $1.3M | FY2019 | Jul 2019 – Aug 2022 |
| Department of Health and Human Services | DESIGNING DRUGS THAT SUPRESS CHRONIC BRAIN INFLAMMATION | $1.1M | FY2005 | Jul 2005 – Aug 2010 |
| Department of Health and Human Services | INHIBITION OF COMPLEMENT PATHWAYS WITH VCP AS A TREATMENT FOR ALZHEIMER'S DISEASE - PROJECT SUMMARY/ABSTRACT VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN (VCP) HAS BEEN SHOWN TO HAVE STRUCTURAL AND FUNCTIONAL SIMILARITY TO HUMAN COMPLEMENT CONTROL PROTEINS. VCP MODULATES THE HUMAN AND RODENT COMPLEMENT SYSTEM. DURING THE PAST TWO DECADES, WE HAVE STUDIED VCP EXTENSIVELY IN A NUMBER OF PRECLINICAL INFLAMMATORY DISEASE MODELS INCLUDING ALZHEIMER’S DISEASE (AD) AND SPINAL CORD INJURY (SCI) AND DEMONSTRATED THAT CONTROLLING COMPLEMENT MEDIATED INFLAMMATION BY VCP HAS SIGNIFICANTLY IMPROVED OUTCOMES, LEADING TO OUR HYPOTHESIS THAT VCP CAN BE POTENTIALLY USED FOR THERAPEUTIC TREATMENTS OF THESE DISEASES. AD IS ONE OF THE MOST DEVASTATING DISEASES AMONGST THE AGING POPULATION IN THE WORLD AND THE 6TH LEADING CAUSE OF DEATH IN THE US. IT IS WELL KNOWN THAT AMYLOID PROTEINS AND PLAQUES ARE ASSOCIATED WITH ACTIVATION OF SEVERAL PROINFLAMMATORY MEDIATORS, ESPECIALLY COMPLEMENT COMPONENTS. INTERESTINGLY, APOE GENOTYPES THAT SIGNIFICANTLY FACILITATE A- DEPOSIT, ARE STRONGLY INVOLVED IN REGULATION OF CLASSICAL COMPLEMENT CASCADE. THESE PRO-INFLAMMATORY MEDIATORS CAN CAUSE DAMAGE ON THEIR OWN AS WELL AS WORKING IN SYNERGY WITH EACH OTHER, ULTIMATELY LEADING TO NEURODEGENERATION. OVER TIME, THE DAMAGING ROLE OF COMPLEMENT COMPONENTS OVERPOWERS THEIR BENEFICIAL EFFECTS AS THE DISEASE PROGRESSES. AS A RESULT, COMPLEMENT PATHWAYS HAVE BECOME POTENTIAL TARGETS FOR DEVELOPING TREATMENTS OF DISEASES SUCH AS AD. TO PROVIDE A PROOF OF CONCEPT, WE INVESTIGATED THE ROLE OF COMPLEMENT PATHWAYS REGULATED BY VCP IN AD MICE MODEL. IN THIS MODEL, VCP WAS SHOWN TO BE EFFECTIVE IN PREVENTING MEMORY LOSS. TO FURTHER DEVELOP VCP AS A POTENTIAL TREATMENT FOR AD, IN THIS SBIR PHASE I STUDY, WE WILL AIM AT CHARACTERIZING HIGH QUALIFY HUMANIZED RECOMBINANT VCP (HRVCP) AND AT THE ASSESSMENT OF CANDIDATE HRVCP IN ANIMAL MODELS IN A MORE CLINICAL RELEVANT MANNER BY AN INDEPENDENT CRO COMPANY WITH TWO SPECIFIC AIMS: 1) TO SUBJECT HRVCP TO A FULL BATTERY OF IN-HOUSE ANALYTICAL CHARACTERIZATION AND STABILITY PROFILING; ; SPECIFIC AIM 2: TO VALIDATE OUR PREVIOUS FINDINGS BY TESTING EFFICACY OF HRVCP IN APP/PS1 AD MODELS WITH COLLABORATION OF AN INDEPENDENT CRO LABORATORY. OUR MILESTONE GOALS INCLUDE DEVELOPMENT OF ACTIVE AND STABLE HRVCP PRE-FORMULATION IN SALINE, PRODUCTION OF MORE HRVCP IF RESOURCES ALLOW, AND VALIDATION OF EFFICACY DATA IN AD MODELS FROM A LABORATORY OTHER THAN OUR OWN. IF WE ARE SUCCESSFUL, PK/SAFETY ASSESSMENTS AND OTHER PRECLINICAL STUDIES OF PURIFIED HRVCP PROTEIN WILL BE THE GOAL OF PHASE II STUDIES, ALONG WITH EVEN MORE RIGOROUS SAFETY STUDIES INCLUDING IN VITRO CARDIOTOXICITY, HEPATOTOXICITY AND BONE MARROW TOXICITY STUDIES IN STEM CELLS DERIVED TISSUE CELLS. WE EXPECT THAT THE SBIR PHASE1 STUDIES WILL LEAD TO DEVELOPMENT OF HRVCP FOR A COMMERCIAL SCALE THERAPEUTIC APPROACH TO TARGET THE PROGRESSION OF NEUROINFLAMMATION AND NEURODEGENERATION ANTICIPATED IN AD PATIENTS. | $552.2K | FY2023 | Feb 2023 – Sep 2024 |
| Department of Health and Human Services | DEVELOPING A PRENATAL BIOLOGIC THERAPY TO MITIGATE ASD RISK FROM MATERNAL AUTOANTIBODIES TO CASPR2 | $479.6K | FY2017 | Aug 2017 – Jul 2021 |
| National Science Foundation | SBIR PHASE I: DEVELOPMENT OF A STOICHIOMETRIC, DIRECT-INJECTED, SOOT-FREE ENGINE FOR HEAVY-DUTY APPLICATIONS | $225K | FY2017 | Jul 2017 – Dec 2018 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT PERSONNEL AND FACILITIES EXPENSES IN RESPONSE TO AND RECOVERY FROM THE COVID-19 PANDEMIC. | $150K | FY2022 | Jan 2022 – Dec 2023 |
| Department of Agriculture | ETHANOL DUAL-FUEL ENGINE RETROFITS TO DISPLACE DIESEL USAGE IN FARM EQUIPMENT | $100K | FY2018 | Jul 2018 – Feb 2019 |
| Department of Health and Human Services | AUTISM SPECTRUM DISORDER DIAGNOSTIC/THERAPEUTIC AGENT | $94.2K | FY2015 | Feb 2015 – Mar 2016 |
| Department of Health and Human Services | A DIAGNOSTIC FOR MATERNAL AUTOAB TO CASPR2 TO PREDICT INCREASED RISK OF AUTISM SPECTRUM DISORDER IN CHILDREN | $88.4K | FY2017 | Aug 2017 – Jul 2018 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT ARTIST FEES FOR THE FESTIVAL FLAMENCO ALBURQUERQUE. | $75K | FY2023 | Jan 2023 – Jun 2023 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT ARTIST FEES FOR THE 35TH ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE. | $75K | FY2022 | Jan 2022 – Jun 2022 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT ARTIST FEES FOR THE FESTIVAL FLAMENCO ALBUQUERQUE. | $70K | FY2024 | Jan 2024 – Jul 2024 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT ARTIST TRAVEL COSTS FOR THE FESTIVAL FLAMENCO ALBUQUERQUE. | $60K | FY2026 | Jan 2026 – Jun 2026 |
| National Endowment for the Arts | TO SUPPORT PERSONNEL AND FACILITIES COSTS IN RESPONSE TO THE COVID-19 PANDEMIC. | $50K | FY2020 | Jul 2020 – Jun 2021 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT TOURING PERFORMANCES OF SEARCHING FOR GOYA. | $30K | FY2025 | Jan 2025 – Dec 2025 |
| National Endowment for the Arts | TO SUPPORT ARTIST FEES FOR THE 34TH ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE. | $30K | FY2021 | Jan 2021 – Jul 2021 |
| National Endowment for the Arts | TO SUPPORT ARTIST FEES FOR THE ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE. | $30K | FY2020 | Jan 2020 – Jun 2020 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT PERFORMANCES ON TOUR OF AN ORIGINAL FLAMENCO PRODUCTION BASED ON FRANCISCO GOYAS ART WITH ACCOMPANYING ENGAGEMENT ACTIVTIES. | $25K | FY2024 | Jan 2024 – Dec 2024 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT THE DEVELOPMENT AND PRODUCTION OF A DANCE WORK BY CHOREOGRAPHER JESÚS MUÑOZ. | $20K | FY2024 | Jul 2024 – Nov 2025 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT JESÚS MUÑOZ FLAMENCOS FIESTA FLAMENCA A FREE DANCE FESTIVAL OF PERFORMANCES AND EDUCATIONAL PROGRAMMING. | $20K | FY2023 | Jun 2023 – Nov 2024 |
| National Endowment for the Arts | TO SUPPORT THE FESTIVAL FLAMENCO INTERNACIONAL DE ALBUQUERQUE. | $20K | FY2017 | Jan 2017 – Jun 2017 |
| National Endowment for the Arts | TO SUPPORT THE CREATION AND PRESENTATION OF "DESEO" (DESIRE), A NEW FLAMENCO WORK BY ARTISTIC DIRECTOR MARTIN SANTANGELO. | $20K | FY2016 | Apr 2016 – Dec 2016 |
| National Endowment for the Arts | TO SUPPORT THE ANNUAL FESTIVAL FLAMENCO INTERNACIONAL DE ALBUQUERQUE. | $20K | FY2016 | Jan 2016 – Jun 2016 |
| National Endowment for the Arts | TO SUPPORT THE PRESENTATION AND TOUR OF A FLAMENCO DANCE BASED ON ANTON CHEKOV'S STORY "THE HUNTSMAN." | $20K | FY2013 | Jan 2013 – Dec 2013 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A LIVE FLAMENCO PRODUCTION BASED ON SELECTED WORKS OF ARTIST FRANCISCO GOYA. | $15K | FY2022 | Jun 2022 – Dec 2023 |
| National Endowment for the Arts | TO SUPPORT THE ANNUAL FESTIVAL FLAMENCO INTERNACIONAL DE ALBURQUERQUE. | $15K | FY2019 | Jan 2019 – Jun 2019 |
| National Endowment for the Arts | TO SUPPORT RESIDENCY ACTIVITIES FOR FLAMENCO ARTISTS TRAVELING FROM SPAIN TO NEW MEXICO. | $15K | FY2018 | Jan 2018 – Dec 2018 |
| Department of Agriculture | COMMUNITY FACILITIES - ECONOMIC IMPACT INITIATIVE GRANTS | $13.8K | FY2011 | Sep 2011 – Aug 2012 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A CONTEMPORARY FLAMENCO DANCE WORK FEATURING PERFORMERS ALICE BLUMENFELD AND FELISE BAGLEY. | $12.5K | FY2025 | Jun 2025 – May 2027 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT A FLAMENCO RESIDENCY PROGRAM AND PUBLIC PERFORMANCES. | $10K | FY2022 | Aug 2022 – Jun 2023 |
| National Endowment for the Arts | PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A THEATER AND FLAMENCO DANCE PROJECT WITH ASSOCIATED PUBLIC PROGRAMMING. | $10K | FY2022 | Jan 2022 – Jun 2023 |
| National Endowment for the Arts | TO SUPPORT THE CREATION AND PRESENTATION OF AN ORIGINAL FLAMENCO INTERPRETATION OF SOPHOCLES PLAY WOMEN OF TRACHIS. | $10K | FY2021 | Jan 2021 – Jun 2022 |
| National Endowment for the Arts | TO SUPPORT THE RESEARCH DEVELOPMENT AND PERFORMANCE OF A NEW DANCE WORK BASED ON THE GREEK MYTH OF DEMETER AND PERSEPHONE. | $10K | FY2018 | Jun 2018 – May 2019 |
| National Endowment for the Arts | TO SUPPORT A RESIDENCY WITH FLAMENCO ARTIST BELÉN MAYA AS PART OF THE MAJAS APPRENTICE PROGRAM. | $10K | FY2018 | Jun 2018 – May 2019 |
| National Endowment for the Arts | TO SUPPORT THE CREATION AND PRESENTATION OF A NEW WORK "LA RONDE. | $10K | FY2017 | Apr 2017 – Dec 2017 |
| National Endowment for the Arts | TO SUPPORT THE MAJAS APPRENTICE PROGRAM. | $10K | FY2016 | Jun 2016 – May 2017 |
| National Endowment for the Arts | TO SUPPORT THE CREATION AND PRESENTATION OF A NEW WORK BASED ON A RUMI POEM CALLED "THE CHRISTIAN, THE MUSLIM, AND THE JEW," BY ARTISTIC DIRECTOR MAR | $10K | FY2015 | Jan 2015 – Jun 2016 |
| National Endowment for the Arts | TO SUPPORT THE CONTINUED DEVELOPMENT AND PRESENTATION OF "ANTIGONA," A FLAMENCO INTERPRETATION OF THE TEXT AND THEMES IN SOPHOCLES' PLAY, "ANTIGONE," | $10K | FY2014 | Jan 2014 – Jun 2015 |
| National Endowment for the Arts | TO SUPPORT A UNITED STATES TOUR OF FLAMENCO DANCE PROGRAMS. | $10K | FY2012 | Jan 2012 – Dec 2012 |
| National Endowment for the Arts | TO SUPPORT A TOUR OF FLAMENCO DANCE PERFORMANCES. | $10K | FY2011 | Jun 2011 – Jun 2012 |
| National Endowment for the Arts | TO SUPPORT A UNITED STATES TOUR OF FLAMENCO DANCE PROGRAMS. | $10K | FY2011 | Jan 2011 – Dec 2011 |
| National Endowment for the Arts | TO SUPPORT THE TOUR OF A SERIES OF FLAMENCO PERFORMANCES. | $10K | FY2010 | Jun 2010 – May 2011 |
| National Endowment for the Arts | TO SUPPORT A TOUR OF FLAMENCO DANCE ACROSS THE UNITED STATES. | $10K | FY2010 | Jan 2010 – Dec 2010 |
| Department of Agriculture | SEC 9007 REAP-RENEW ENERGY EFFICIENCY IMPROVE GRANTS $20 000 OR LESS (MAN) | $8,563 | FY2010 | Sep 2010 – Sep 2012 |
| Department of Energy | COMBUSTION OF LIQUID FUELS IN THE AIR CORE OF ROTATING WATER FOR APPLICATION IN A DOWNHOLE STEAM GENERATOR | $0 | FY2013 | Jun 2013 – Mar 2014 |
National Science Foundation
$1.4M
SBIR PHASE II: DEVELOPMENT OF A STOICHIOMETRIC, DIRECT-INJECTED, SOOT-FREE ENGINE FOR HEAVY-DUTY APPLICATIONS
Department of Energy
$1.3M
COMBUSTION GEOMETRY OPTIMIZATION TO INCREASE ALCOHOL-FUELED MCCI EFFICIENCY
Department of Health and Human Services
$1.1M
DESIGNING DRUGS THAT SUPRESS CHRONIC BRAIN INFLAMMATION
Department of Health and Human Services
$552.2K
INHIBITION OF COMPLEMENT PATHWAYS WITH VCP AS A TREATMENT FOR ALZHEIMER'S DISEASE - PROJECT SUMMARY/ABSTRACT VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN (VCP) HAS BEEN SHOWN TO HAVE STRUCTURAL AND FUNCTIONAL SIMILARITY TO HUMAN COMPLEMENT CONTROL PROTEINS. VCP MODULATES THE HUMAN AND RODENT COMPLEMENT SYSTEM. DURING THE PAST TWO DECADES, WE HAVE STUDIED VCP EXTENSIVELY IN A NUMBER OF PRECLINICAL INFLAMMATORY DISEASE MODELS INCLUDING ALZHEIMER’S DISEASE (AD) AND SPINAL CORD INJURY (SCI) AND DEMONSTRATED THAT CONTROLLING COMPLEMENT MEDIATED INFLAMMATION BY VCP HAS SIGNIFICANTLY IMPROVED OUTCOMES, LEADING TO OUR HYPOTHESIS THAT VCP CAN BE POTENTIALLY USED FOR THERAPEUTIC TREATMENTS OF THESE DISEASES. AD IS ONE OF THE MOST DEVASTATING DISEASES AMONGST THE AGING POPULATION IN THE WORLD AND THE 6TH LEADING CAUSE OF DEATH IN THE US. IT IS WELL KNOWN THAT AMYLOID PROTEINS AND PLAQUES ARE ASSOCIATED WITH ACTIVATION OF SEVERAL PROINFLAMMATORY MEDIATORS, ESPECIALLY COMPLEMENT COMPONENTS. INTERESTINGLY, APOE GENOTYPES THAT SIGNIFICANTLY FACILITATE A- DEPOSIT, ARE STRONGLY INVOLVED IN REGULATION OF CLASSICAL COMPLEMENT CASCADE. THESE PRO-INFLAMMATORY MEDIATORS CAN CAUSE DAMAGE ON THEIR OWN AS WELL AS WORKING IN SYNERGY WITH EACH OTHER, ULTIMATELY LEADING TO NEURODEGENERATION. OVER TIME, THE DAMAGING ROLE OF COMPLEMENT COMPONENTS OVERPOWERS THEIR BENEFICIAL EFFECTS AS THE DISEASE PROGRESSES. AS A RESULT, COMPLEMENT PATHWAYS HAVE BECOME POTENTIAL TARGETS FOR DEVELOPING TREATMENTS OF DISEASES SUCH AS AD. TO PROVIDE A PROOF OF CONCEPT, WE INVESTIGATED THE ROLE OF COMPLEMENT PATHWAYS REGULATED BY VCP IN AD MICE MODEL. IN THIS MODEL, VCP WAS SHOWN TO BE EFFECTIVE IN PREVENTING MEMORY LOSS. TO FURTHER DEVELOP VCP AS A POTENTIAL TREATMENT FOR AD, IN THIS SBIR PHASE I STUDY, WE WILL AIM AT CHARACTERIZING HIGH QUALIFY HUMANIZED RECOMBINANT VCP (HRVCP) AND AT THE ASSESSMENT OF CANDIDATE HRVCP IN ANIMAL MODELS IN A MORE CLINICAL RELEVANT MANNER BY AN INDEPENDENT CRO COMPANY WITH TWO SPECIFIC AIMS: 1) TO SUBJECT HRVCP TO A FULL BATTERY OF IN-HOUSE ANALYTICAL CHARACTERIZATION AND STABILITY PROFILING; ; SPECIFIC AIM 2: TO VALIDATE OUR PREVIOUS FINDINGS BY TESTING EFFICACY OF HRVCP IN APP/PS1 AD MODELS WITH COLLABORATION OF AN INDEPENDENT CRO LABORATORY. OUR MILESTONE GOALS INCLUDE DEVELOPMENT OF ACTIVE AND STABLE HRVCP PRE-FORMULATION IN SALINE, PRODUCTION OF MORE HRVCP IF RESOURCES ALLOW, AND VALIDATION OF EFFICACY DATA IN AD MODELS FROM A LABORATORY OTHER THAN OUR OWN. IF WE ARE SUCCESSFUL, PK/SAFETY ASSESSMENTS AND OTHER PRECLINICAL STUDIES OF PURIFIED HRVCP PROTEIN WILL BE THE GOAL OF PHASE II STUDIES, ALONG WITH EVEN MORE RIGOROUS SAFETY STUDIES INCLUDING IN VITRO CARDIOTOXICITY, HEPATOTOXICITY AND BONE MARROW TOXICITY STUDIES IN STEM CELLS DERIVED TISSUE CELLS. WE EXPECT THAT THE SBIR PHASE1 STUDIES WILL LEAD TO DEVELOPMENT OF HRVCP FOR A COMMERCIAL SCALE THERAPEUTIC APPROACH TO TARGET THE PROGRESSION OF NEUROINFLAMMATION AND NEURODEGENERATION ANTICIPATED IN AD PATIENTS.
Department of Health and Human Services
$479.6K
DEVELOPING A PRENATAL BIOLOGIC THERAPY TO MITIGATE ASD RISK FROM MATERNAL AUTOANTIBODIES TO CASPR2
National Science Foundation
$225K
SBIR PHASE I: DEVELOPMENT OF A STOICHIOMETRIC, DIRECT-INJECTED, SOOT-FREE ENGINE FOR HEAVY-DUTY APPLICATIONS
National Endowment for the Arts
$150K
PURPOSE: TO SUPPORT PERSONNEL AND FACILITIES EXPENSES IN RESPONSE TO AND RECOVERY FROM THE COVID-19 PANDEMIC.
Department of Agriculture
$100K
ETHANOL DUAL-FUEL ENGINE RETROFITS TO DISPLACE DIESEL USAGE IN FARM EQUIPMENT
Department of Health and Human Services
$94.2K
AUTISM SPECTRUM DISORDER DIAGNOSTIC/THERAPEUTIC AGENT
Department of Health and Human Services
$88.4K
A DIAGNOSTIC FOR MATERNAL AUTOAB TO CASPR2 TO PREDICT INCREASED RISK OF AUTISM SPECTRUM DISORDER IN CHILDREN
National Endowment for the Arts
$75K
PURPOSE: TO SUPPORT ARTIST FEES FOR THE FESTIVAL FLAMENCO ALBURQUERQUE.
National Endowment for the Arts
$75K
PURPOSE: TO SUPPORT ARTIST FEES FOR THE 35TH ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE.
National Endowment for the Arts
$70K
PURPOSE: TO SUPPORT ARTIST FEES FOR THE FESTIVAL FLAMENCO ALBUQUERQUE.
National Endowment for the Arts
$60K
PURPOSE: TO SUPPORT ARTIST TRAVEL COSTS FOR THE FESTIVAL FLAMENCO ALBUQUERQUE.
National Endowment for the Arts
$50K
TO SUPPORT PERSONNEL AND FACILITIES COSTS IN RESPONSE TO THE COVID-19 PANDEMIC.
National Endowment for the Arts
$30K
PURPOSE: TO SUPPORT TOURING PERFORMANCES OF SEARCHING FOR GOYA.
National Endowment for the Arts
$30K
TO SUPPORT ARTIST FEES FOR THE 34TH ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE.
National Endowment for the Arts
$30K
TO SUPPORT ARTIST FEES FOR THE ANNUAL FESTIVAL FLAMENCO ALBURQUERQUE.
National Endowment for the Arts
$25K
PURPOSE: TO SUPPORT PERFORMANCES ON TOUR OF AN ORIGINAL FLAMENCO PRODUCTION BASED ON FRANCISCO GOYAS ART WITH ACCOMPANYING ENGAGEMENT ACTIVTIES.
National Endowment for the Arts
$20K
PURPOSE: TO SUPPORT THE DEVELOPMENT AND PRODUCTION OF A DANCE WORK BY CHOREOGRAPHER JESÚS MUÑOZ.
National Endowment for the Arts
$20K
PURPOSE: TO SUPPORT JESÚS MUÑOZ FLAMENCOS FIESTA FLAMENCA A FREE DANCE FESTIVAL OF PERFORMANCES AND EDUCATIONAL PROGRAMMING.
National Endowment for the Arts
$20K
TO SUPPORT THE FESTIVAL FLAMENCO INTERNACIONAL DE ALBUQUERQUE.
National Endowment for the Arts
$20K
TO SUPPORT THE CREATION AND PRESENTATION OF "DESEO" (DESIRE), A NEW FLAMENCO WORK BY ARTISTIC DIRECTOR MARTIN SANTANGELO.
National Endowment for the Arts
$20K
TO SUPPORT THE ANNUAL FESTIVAL FLAMENCO INTERNACIONAL DE ALBUQUERQUE.
National Endowment for the Arts
$20K
TO SUPPORT THE PRESENTATION AND TOUR OF A FLAMENCO DANCE BASED ON ANTON CHEKOV'S STORY "THE HUNTSMAN."
National Endowment for the Arts
$15K
PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A LIVE FLAMENCO PRODUCTION BASED ON SELECTED WORKS OF ARTIST FRANCISCO GOYA.
National Endowment for the Arts
$15K
TO SUPPORT THE ANNUAL FESTIVAL FLAMENCO INTERNACIONAL DE ALBURQUERQUE.
National Endowment for the Arts
$15K
TO SUPPORT RESIDENCY ACTIVITIES FOR FLAMENCO ARTISTS TRAVELING FROM SPAIN TO NEW MEXICO.
Department of Agriculture
$13.8K
COMMUNITY FACILITIES - ECONOMIC IMPACT INITIATIVE GRANTS
National Endowment for the Arts
$12.5K
PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A CONTEMPORARY FLAMENCO DANCE WORK FEATURING PERFORMERS ALICE BLUMENFELD AND FELISE BAGLEY.
National Endowment for the Arts
$10K
PURPOSE: TO SUPPORT A FLAMENCO RESIDENCY PROGRAM AND PUBLIC PERFORMANCES.
National Endowment for the Arts
$10K
PURPOSE: TO SUPPORT THE CREATION AND PRESENTATION OF A THEATER AND FLAMENCO DANCE PROJECT WITH ASSOCIATED PUBLIC PROGRAMMING.
National Endowment for the Arts
$10K
TO SUPPORT THE CREATION AND PRESENTATION OF AN ORIGINAL FLAMENCO INTERPRETATION OF SOPHOCLES PLAY WOMEN OF TRACHIS.
National Endowment for the Arts
$10K
TO SUPPORT THE RESEARCH DEVELOPMENT AND PERFORMANCE OF A NEW DANCE WORK BASED ON THE GREEK MYTH OF DEMETER AND PERSEPHONE.
National Endowment for the Arts
$10K
TO SUPPORT A RESIDENCY WITH FLAMENCO ARTIST BELÉN MAYA AS PART OF THE MAJAS APPRENTICE PROGRAM.
National Endowment for the Arts
$10K
TO SUPPORT THE CREATION AND PRESENTATION OF A NEW WORK "LA RONDE.
National Endowment for the Arts
$10K
TO SUPPORT THE MAJAS APPRENTICE PROGRAM.
National Endowment for the Arts
$10K
TO SUPPORT THE CREATION AND PRESENTATION OF A NEW WORK BASED ON A RUMI POEM CALLED "THE CHRISTIAN, THE MUSLIM, AND THE JEW," BY ARTISTIC DIRECTOR MAR
National Endowment for the Arts
$10K
TO SUPPORT THE CONTINUED DEVELOPMENT AND PRESENTATION OF "ANTIGONA," A FLAMENCO INTERPRETATION OF THE TEXT AND THEMES IN SOPHOCLES' PLAY, "ANTIGONE,"
National Endowment for the Arts
$10K
TO SUPPORT A UNITED STATES TOUR OF FLAMENCO DANCE PROGRAMS.
National Endowment for the Arts
$10K
TO SUPPORT A TOUR OF FLAMENCO DANCE PERFORMANCES.
National Endowment for the Arts
$10K
TO SUPPORT A UNITED STATES TOUR OF FLAMENCO DANCE PROGRAMS.
National Endowment for the Arts
$10K
TO SUPPORT THE TOUR OF A SERIES OF FLAMENCO PERFORMANCES.
National Endowment for the Arts
$10K
TO SUPPORT A TOUR OF FLAMENCO DANCE ACROSS THE UNITED STATES.
Department of Agriculture
$8,563
SEC 9007 REAP-RENEW ENERGY EFFICIENCY IMPROVE GRANTS $20 000 OR LESS (MAN)
Department of Energy
$0
COMBUSTION OF LIQUID FUELS IN THE AIR CORE OF ROTATING WATER FOR APPLICATION IN A DOWNHOLE STEAM GENERATOR
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2024 · Source: IRS e-Filed Form 990
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
WarningTax-exempt status was revoked on May 15, 2012
Reinstated on October 15, 2012
Exemption type: 00
990-N (e-Postcard) Filing History
This organization files simplified Form 990-N (annual gross receipts ≤ $50,000).
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2024IRS e-File | $249.6K | $249.6K | $246.7K | $3,866 | $3,866 |
| 2023 | $247.2K | $247.2K | $257.4K | $944 | $944 |
| 2022 | $165.9K | — | $165.3K | $11.2K | — |
| 2021 | $146.1K | — | $137.7K |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | |
| 2022 | 990-EZ | DataIRS e-File |
Financial data: IRS e-Filed Form 990 (Tax Year 2024)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
Revocation status: IRS Auto-Revocation List
| Total |
|---|
| Delilah Buitron | Pres/art Direct | 42 | $30.4K | $0 | $0 | $30.4K |
Delilah Buitron
Pres/art Direct
$30.4K
Hrs/Wk
42
Compensation
$30.4K
Related Orgs
$0
Other
$0
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Julie Kinzie | Comm Dir | 7 | $615 | $0 | $0 | $615 |
| Kimberly Magill | Secretary | 10 | $1,000 | $0 | $0 | $1,000 |
Julie Kinzie
Comm Dir
$615
Hrs/Wk
7
Compensation
$615
Related Orgs
$0
Other
$0
Kimberly Magill
Secretary
$1,000
Hrs/Wk
10
Compensation
$1,000
Related Orgs
$0
Other
$0
| $10.5K |
| — |
| 2020 | $78.7K | — | $88.6K | $2,063 | — |
| 2019 | $127K | — | $130.8K | $12K | — |
| 2018 | $106.2K | — | $117.2K | $15.8K | — |
| 2021 | 990-EZ | Data |
| 2020 | 990-EZ | Data |
| 2019 | 990-EZ | Data |
| 2018 | 990-EZ | Data |